Skip to main content
SpringerLink
Log in

Adjuvante Therapie des Nierenzellkarzinoms

  • Published:
Der Urologe B

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Adler A, Gillon G, Lurie H, Shahm J, Loven D, Shachter Y, Shani A, Servadio C, Stein JA (1987) Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormonoimmunoversus hormonotherapy. J Biol Response Mod 6: 610–624

    CAS  PubMed  Google Scholar 

  2. Aref I, Bociek G, Salhani D (1997) Is post-operative radiation for renal cell carcinoma justified? Radiother Oncol 43: 155–157

    Article  CAS  PubMed  Google Scholar 

  3. Aso Y, Homma Y (1996) Adjuvant interferon therapy for renal cell carcinoma. Akt Urol 27: 9–12

    Article  Google Scholar 

  4. Finney R (1973) The value of radiotherapy in the treatment of hypernephroma — a clinical Trial. Br J Urol 45: 258–269

    Article  CAS  PubMed  Google Scholar 

  5. Fischer C (1996) ai]Leitlinien zur aktiv-spezifischen Immuntherapie beim Nierenzell-karzinom. Urol [B] 36: 253–255

    Article  Google Scholar 

  6. Galligioni E, Francini M, Quaia M, Carbone A, Spada A, Sacco C, Favoro D, Santarosa M, Car-mignani G, DiDonna D, Mazza G, Viggiano S, Fiaccavento G, DaIBo V, Talamini R (1993) Randomized study of adjuvant immunotherapy with autologous tumor cells and BCG in renal cancer. Ann New York Acad Sei 690: 367–369

    Article  CAS  Google Scholar 

  7. Goepel M, Rübben H (1991) Adjuvant therapy in renal cancer. World J Urol 9: 232–236

    Article  Google Scholar 

  8. Guinan PD, Vogelzang NJ, Fremgen AM, Chmiel JS, Sylvester JL, Sener SF, Imperato JP and Members of the cancer incidence and end results committee (1995) Renal cell carcinoma: tumor size, stage and survival. J Urol 153: 901–903

    Article  CAS  PubMed  Google Scholar 

  9. Hinkel A, deRiese W, Alefelder J, Falkenberg FW, Senge T, Hertie H (1995) Active specific immunotherapy with an autologous virus-modified tumour cell vaccine in human renal cell carcinoma (RCC). Eur J Cancer 31A: 1719–1720

    Article  CAS  PubMed  Google Scholar 

  10. Hrushesky WJ, Murphy GP (1977) Current status of the therapy of advanced renal cell carcinoma. J Surg Oncol 9: 277–288

    Article  CAS  PubMed  Google Scholar 

  11. Johnsen JA, Hellsten S (1997) Lymphatogen-ous spread of renal cell carcinoma: an authopsy study. J Urol 157: 450–453

    Article  CAS  PubMed  Google Scholar 

  12. Juusela H, Malmio K, Alfthan O, Oravisto KJ (1977) Preoperative irradiation in the treatment of renal adenocarcinoma. Scand J Urol Nephrol 11: 277–281

    Article  CAS  PubMed  Google Scholar 

  13. Kirchner HH, Anton P, Atzpodien J (1995) Adjuvant treatment of locally advanced renal cell cancer with autologous virus-modified tumor vakzines. World J Urol 13: 171–173

    Article  CAS  PubMed  Google Scholar 

  14. Kriegmair M, Oberneder R (1995) Die Tumor-zellvakzinierung zur Behandlung des Nierenzellkarzinoms. Urol [A] 34: 204–207

    CAS  Google Scholar 

  15. Lopez-Hänninen E, Kirchner H, Atzpodien J (1996) Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution Patients. J Urol 155: 19–25

    Article  PubMed  Google Scholar 

  16. Luiten RM, Coney LR, Fleuren GF, Warnaar SO, Litvinov SV (1996) Generation of chimeric bispecific G 250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma. Br J Cancer 74: 735–744

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Masuda F, Nakada J, Kondo I, Furuta N (1992) Adjuvant chemotherapy with vinblastine, adriamycin and UFT for renal cell carcinoma. Cancer Chemother Pharmacol 30: 477–479

    Article  CAS  PubMed  Google Scholar 

  18. Migliari R, Muscas G, Solinas A, Melis M, Ionta MT, Massidda B, Usai E (1995) Is there a role for adjuvant immunochemotherapy after radical nephrectomy in pT2–3N0M0 renal cell carcinomas? J Chemother 7: 240–245

    Article  CAS  PubMed  Google Scholar 

  19. Naito S, Kumazawa J, Omoto T, Iguchi A, Sagiyama K, Osada Y, Hiratsuka Y (1997) Postoperative UFT adjuvant and the risk factors for recurrence in renal cell carcinoma: a long-term follow-up study. Int J Urol 4: 8–12

    Article  CAS  PubMed  Google Scholar 

  20. Pizzocaro G, Piva L, DiFronzo G (1987) Adjuvant medroxyprogesteron acetate to radical nephrectomy in renal cell cancer: 5 years result of a prospective randomized study. J Urol 138: 1379–1381

    CAS  PubMed  Google Scholar 

  21. Rabinovitch RA, Zelfsky MJ, Gaynor JJ, Fuks Z (1994) Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy. J Clin Oncol 12: 206–212

    CAS  PubMed  Google Scholar 

  22. Repmann R, Wagner S, Richter A (1997) Adjuvant therapy of renal cell carcinoma with active-specific-immunotherapy (ASI) using autologous tumor vaccine. Anticancer Res 17: 2879–2882

    CAS  PubMed  Google Scholar 

  23. Riethmüller G, Schneider-Gädicke E, Schlimok G, Schmiegel W, Raab R, Höffken K, Gruber R, Pichlmaier H, Hirche H, Pichlmayr R, Buggisch P, Witte J et al (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes C colorectal carcinoma. Lancet 343: 1177–1184

    Article  PubMed  Google Scholar 

  24. Wenderoth UK (1993) Adjuvant therapy of renal cell cancer (RCC) with interferon-alpha-2 a. Preliminary results of the Delta-P-StudyGroup. J Urol 149: 447

    Google Scholar 

  25. Yagoda A (1989) Chemotherapy in renal cell carcinoma. Semin Urol 7: 199–206

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologische Klinik und Poliklinik, Klinikum Großhadern, Ludwig-Maximilians-Universität München, Marchioninistraße 15, D-81377, München

    R. Oberneder, M. Siebels & A. Hofstetter

Authors
  1. R. Oberneder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Siebels
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Hofstetter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oberneder, R., Siebels, M. & Hofstetter, A. Adjuvante Therapie des Nierenzellkarzinoms. Der Urologe B 38, 342–346 (1998). https://doi.org/10.1007/s001310050213

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001310050213

Search

Navigation